VolitionRx Limited has expanded its Agreement with Fujifilm Vet Systems Co. Ltd in Japan to include Volition's chemiluminescent immunoassay version of the Nu.Q Vet Cancer Test via the Immunodiagnostic Systems i10 automated analyzer platform, for a new five year initial term. The aim is to launch the automated cancer test in the summer of 2025, in response to the increasing demand amongst Japanese veterinarians. The expansion presents an exciting revenue opportunity for Volition.
Company Information
Company
VolitionRx
Location
Henderson, Nevada, United States
About
VolitionRx Limited is a multi-national epigenetics company dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. The company is focused on advancing the science of epigenetics and developing simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis.
HendersonBiotechnologyHealth CareGeneticsTherapeutics